Yues International Holdings Group Ltd. has announced a strategic decision to reallocate resources to bolster its Traditional Chinese Medicine (TCM) business. This move is intended to capture synergies, enhance the company's value chain, and generate long-term value for shareholders. The company has decided to modify the use of proceeds from a recent share placing, with approximately HK$30.0 million remaining unutilized. These funds were initially earmarked for the development of the Intelligent Logistics Services Business but will now support the expansion of the TCM sector. The board believes this change is in the best interest of the company and its shareholders, ensuring no adverse effects on existing operations. Yues International remains focused on maximizing the potential of its TCM business as part of its growth strategy.